Patent · US Active

Humanized anti-complement factor Bb antibodies and uses thereof

US11999780B2 · kind B2 · utility

0Cited by

4References

17Claims

0Family size

Assignee

Genzyme Corporation · US

Inventors

Graham Parry · South San Francisco, US
Stephen Moore · Edmonton, CA
Michael Storek · Cambridge, US
Nina C. Leksa · Bound Brook Junction, US

Key dates

Filing date	Dec 21, 2021
Grant date	Jun 4, 2024
Priority date	—
Expiry date	Dec 21, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are humanized anti-factor Bb antibodies, methods of producing the antibodies and methods of using the antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.